Anti-inflammatory potential of melanocortin receptor-directed drugs

Annals of the New York Academy of Sciences

Volumn 994, Issue , 2003, Pages 84-89

  Skottner, A ^a,b   Post, C ^a,c   Ocklind, A ^a   Seifert, E ^a   Liutkevicius, E ^d   Meskys, R ^d   Pilinkiene, A ^d   Biziuleviciene, G ^d   Lundstedt, T ^a,b  

^a Melacure Therapeutics AB   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Agonist; Anti inflammation; Edema; Low molecular weight compounds; MC1R

Indexed keywords

ALPHA INTERMEDIN; CYCLIC AMP; CYTOKINE; DEXAMETHASONE; EL 13; GLUCOCORTICOID; HORMONE RECEPTOR AFFECTING AGENT; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BIOASSAY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG SYNTHESIS; EDEMA; FEMALE; FOOD INTAKE; IMMUNOMODULATION; LIGAND BINDING; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PHARMACOLOGICAL BLOCKING; RECEPTOR BINDING; RECEPTOR BLOCKING;

ANIMALIA;

EID: 0037713327     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03165.x     Document Type: Conference Paper

References (14)

1. CHHAJLANI, V. & J.E.S. WIKBERG. 1992. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309: 417-420.
2. STAR, R.A., N. RAJORA, et al. 1995. Evidence of autocrine modulation of macrophage nitric oxide synthase by α-melanocyte stimulating hormone. Proc. Natl. Acad. Sci. USA 92: 8016-8020.
3. HARTMEYER, M., T. SCHOLZEN, et al. 1997. Human dermal microvascular endothelial cells express the melanocortin receptor type i and produce levels of IL-8 upon stimulation with alpha-melanocyte stimulating hormone. J. Immunol. 159: 1930-1937.
4. CATANIA, A., A. RAJORA, et al. 1996. The neuropeptide αMSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17: 675-679.
5. BECHER, E., K. MAHNKE, et al. 1999. Human peripheral blood derived dendritic cells express functional melanocortin receptor MC1R. Ann. N.Y. Acad. Sci. 885: 188-195.
6. LUGER, T.A., T. SCHOLZEN, et al. 1997. The role of α-melanocyte stimulating hormone in cutaneous biology. J. Invest. Dermatol. Symp. Proc. 2: 87-93.
7. GRABBE, S., R.S. BHARDWAJ, et al. 1996. α-Melanocyte-stimulating-hormone induces hapten-specific tolerance in mice. J. Immunol. 156: 473-478.
8. HILTZ, M.E. & J.M. LIPTON. 1990. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11: 979-982.
9. CATANIA, A. & J.W. LIPTON. 1993. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14: 564-576.
10. WIKBERG, J.E.S., R. MUCENIECE, et al. 2000. New aspects on the melanocortins and their receptors. Pharmacol. Res. 42: 393-420.
11. RAJORA, N., G. BOCCOLI, et al. 1997. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381-385.
12. THODY, A.J., K. RIDLEY, et al. 1983. MSH peptides are present in mammalian skin. Peptides 4: 813-816.
13. SLOMINSKI, A., J. WORTSMAN, et al. 1993. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J. Lab. Clin. Med. 122: 658-666.
14. ALBINSSON, A., G. ANDERSSON, et al. 1993. Use of neuroendocrine effects in discrimination between CNS-active drugs in the rat. Drug Dev. Res. 29: 227-234.